Abstract
Raoultella ornithinolytica is a rare opportunistic aerobic gram-negative bacillus that naturally exists in soil, water and plants. The pathogen has been described in association with diabetic foot infections, biliary infections, bacteraemia and native and prosthetic joint infections. Fat necrosis and wound infection following breast reduction surgery or other plastic surgeries caused by this pathogen have not been previously described. We present a case of bilateral fat necrosis, wound infection and dehiscence in a 24-year-old woman with no significant past medical problems. She initially had an uneventful early postoperative course but 3 weeks after surgery noticed pain and discharge from both nipple/areola area of both breasts which later developed into full-thickness fat necrosis and complete destruction of the nipple areolar complex. R. ornithinolytica, Escherichia coli and Enterococcus faecalis were identified from wound exudate cultures. She was treated with surgical debridement and 2 weeks of appropriate antibiotics with a favourable outcome.
Keywords: infectious diseases, breast surgery, plastic and reconstructive surgery
Background
Raoultella ornithinolytica is a rare gram-negative bacterium that is both a human commensal and free living in the environment.1 As a group, they have been described in several aquatic and non-aquatic environments including hospital settings.2 Pathologically, they have been associated with a limited but varied number of infections but to our knowledge, no previous reports of wound infection after breast reduction surgery has been attributable to this organism. This presentation is a case of bilateral wound infection and fat necrosis following breast reduction surgery in a young immunocompetent woman which was successfully treated with antibiotics and surgical debridement.
Case presentation
A 24-year-old woman with no significant past medical problems underwent bilateral breast reduction surgery during which 1740 g and 1610 g of breast tissue were removed from the right and left breasts, respectively. She initially had an uneventful postoperative course. Three weeks after her surgery, however, she reported pain and wound discharge around the nipple/areola area of both breasts. Despite treatment with oral clindamycin and daily wound care, the symptoms got worse with increasing pain, discharge, fever and chills, prompting in-patient admission approximately 4 weeks from her initial surgery.
Evaluation at admission showed low-grade fever of 100.3oF, heart rate 93 beats/minute and blood pressure 111/60 mm Hg. Examination of the breasts showed wound dehiscence around both nipple areolar complex with evidence of fat necrosis. The wound on the left breast appear worse compared with the right with complete destruction of the left nipple areolar complex (figures 1 and 2). Wound cultures were obtained for bacterial, fungal and mycobacterial cultures, and she was started empirically on intravenous clindamycin 600 mg every 8 hours and ciprofloxacin 400 mg intravenously every 12 hours. Fungal and mycobacterial cultures were negative but bacterial cultures grew Escherichia coli, Enterococcus faecalis and R. ornithinolytica. Specifically, the R. ornithinolytica grew on routine plate media (blood, chocolate and eosin methylene blue) and was definitively identified by the MicroScan Walkway 96 plus system. All the identified pathogens were sensitive to multiple antibiotic classes, and multidrug resistance was not a significant consideration. The R. ornithinolytica was only resistant to ampicillin and trimethoprim/sulfamethoxazole but was sensitive to amikacin, cefazolin, cefotaxime, ceftriaxone, ciprofloxacin, levofloxacin and gentamicin.
Figure 1.

Left breast before debridement showing wound dehiscence and extensive necrosis of the fatty component of the breasts with complete destruction of the nipple areolar complex.
Figure 2.

Right breast before debridement showing wound dehiscence and fat necrosis. Part of the nipple areolar complex is still preserved.
Investigations
The patient’s laboratory parameters at the time of admission revealed a white blood cell count of 6.9×109/L, haemoglobin of 10.8 g/dL, platelet count of 314×109/L and creatinine of 1.0 mg/dL. Other laboratory parameters including HIV antigen/antibody testing were unremarkable.
Treatment
After consultation with infectious diseases team, her antibiotic regimen was changed to intravenous ampicillin and intravenous ciprofloxacin, based on the susceptibility results of all the pathogens identified. She subsequently underwent surgical debridement and bilateral wound vacuum assisted closure application to promote wound healing. Pathology of debrided breast tissue confirmed fat necrosis with acute and chronic inflammation.
Outcome and follow-up
She was discharged in stable condition on two additional weeks of oral amoxicillin and ciprofloxacin. After debridement, examination of the wound showed healthy granulation tissue (figures 3 and 4). At subsequent clinical follow-up weeks later, both breast wounds showed no drainage or signs of infection and there was evidence of good wound healing. She eventually had a complete recovery.
Figure 3.

Left breast after debridement showing healthy granulation tissue.
Figure 4.

Right breast after debridement showing healthy granulation tissue.
Discussion
Raoultella are aerobic, non-motile, gram-negative bacilli belonging to the family of Enterobacteriaceae. They are previously classified under the genus Klebsiella but differ in the sense that the genus uses histamine as the only source of carbon.3 Klebsiella on the other hand are non-histamine producers.2 Raoultella are found in the natural environment including plants, water, soil and insects. R. ornithinolytica, one of the three pathogens that make up the genus ‘Raoultella’ are colonisers of the gastrointestinal and upper respiratory tracts1 4 but have also been described in hospital environments and could therefore be associated with nosocomial infections.2 5 Most human infections are opportunistic and caused by R. ornithinolytica and Raoultella planticola.6
R. ornithinolytica as well as R. planticola elaborates histidine decarboxylase, an enzyme which converts histidine to histamine. Both bacteria are thus frequent causes of Scombroid or histamine fish poisoning which typically results from ingestion of decomposing fish.2
R. ornithinolytica is a rare cause of infections in humans and only a handful cases have been published to date. Infections attributable to R. ornithinolytica include relatively serious infections such as bacteraemia, catheter-related infections, sepsis, pneumonia, native and prosthetic joint infection, biliary infections and peritonitis.7–13
Wound infection associated with R. ornithinolytica has also been sparsely reported, especially in diabetics7 14 but not in relation to breast reduction surgery or associated with fat necrosis. Seng et al described a case series of 112 pathogenic R. ornithinolytica infections, out of which 13% were related to skin and soft tissue.5 Only one case in this series was attributable to breast abscess, but the authors did not specify whether there was any preceding breast surgery procedure. No other reports of Raoultella skin or soft tissue infection related to the breasts were encountered during our literature search.
The pathogenesis of R. ornithinolytica has been linked to different factors including formation of biofilms, production of toxins, elaboration of carbapenemases and hydrolases, as well as other virulent factors such as the polysaccharide capsule, siderophores and fimbriae.15–17 It has also been suggested that the presence of a chromosomal bla gene likely plays a key role in the mechanism of beta-lactam resistance attributable to R. ornithinolytica.17 18
Microbiological identification and diagnosis is made possible with several available options including biochemical methods, Microscan (as in our case), Vitek 2 or matrix-assisted laser desorption ionisation-time of flight mass spectrometry. Some challenges with identification are, however, sometimes encountered especially with ornithine decarboxylase negative R. ornithinolytica strains which often requires genetic or molecular methods such as amplification of chromosomal bla, rpoB and 16 s ribosomal DNA genes.5 15 19–21
R. ornithinolytica are naturally resistant to aminopenicillins as typical for most Klebsiella isolates due to the elaboration of chromosomally mediated beta-lactamases.17 22 Generally speaking, however, R. ornithinolytica is sensitive to a good number of antibiotics (as demonstrated by our case) including higher generation cephalosporins, piperacillin-tazobactam, carbapenems, co-trimoxazole and fluoroquinolones.12 14 22 Some authors have, however, reported resistance to some of these agents and multidrug resistant strains including KPC and NDM-1 have been well described.15 16 18 19 23 For example, antibiotic resistance in the case series reported by Seng was relatively high, up to 13% to co-trimoxazole and 6% to quinolones.5 Even though the R. ornithinolytica in our case was resistant to ampicillin, we included ampicillin and amoxicillin in the treatment regimen to provide adequate coverage for all the implicated pathogens, especially Enterococcus. For Raoultella, we suggest initial empirical antibiotic such as higher generation cephalosporin, piperacillin-tazobactam or a carbapenem pending antibiotic susceptibility. When multidrug resistance is encountered, combination therapy may be warranted.4
Our case had polymicrobial involvement and this observation has been previously noted by other authors.5 18 The source of R. ornithinolytica infection in our patient could be the environment and not necessarily hospital acquired as previously noted also in some reports.24 25
There have been several suggested risk factors associated with Raoultella infections. Notable among these include: previous long-term antibiotic therapy,18 diabetes mellitus,7 26 cancer and chemotherapy,11 12 19 27 28 chronic kidney disease, intensive care unit stay, indwelling catheter29 and immunodeficiency.8 9 30 For example, in a small series of 57 patients, Boattini et al reported associated immunodeficiency in 64% of R. ornithinolytica and 56% of R. planticola infections.31 Also, 25% of patients in the report by Seng et al had one form of immunodeficiency.5 While the statistical association between these risk factors and Raoultella infection in a few of these studies is proven, others appear to be weak, non-existent or not reported. None of these risk factors was present in our case.
The data accuracy of the mortality attributable to Raoultella infections is limited by the sparsity of cases. Mortality rate ranges broadly from 8% in larger case series to 100% in smaller series and tend to be slightly higher with R. planticola compared with R. ornithinolytica infections.5 18 31 Mortality tends to be high when there is associated bacteraemia and may still result despite appropriate antibiotic selection.19 32
The wound infection in our case was associated with fat necrosis. Fat necrosis is a relatively uncommon complication of breast reduction surgery, ranging from 5% in a smaller series to 8% in a larger series involving 2142 breast reduction procedures.29 33 Needless to say, that under this circumstance, adequate surgical debridement in combination with appropriate antibiotic therapy is often necessary for a favourable outcome.34
In conclusion, this case represents polymicrobial wound infection that includes R. ornithinolytica isolate in an immunocompetent host with no identifiable risk factors. The extensive tissue destruction may reflect the aggressiveness and virulence of this pathogen. Diagnosis could be challenging but there are several diagnostic tools available. Treatment providers should be familiar with the clinical spectrum, diagnostic and treatment options as well as the potential for multidrug resistance.
Patient’s perspective.
I did everything right as instructed by my surgeon, and I am very surprised and actually upset that I still develop this aggressive infection. I am, however, happy with my response to antibiotic treatment and hope other doctors learn from my experience.
Learning points.
Raoultella ornithinolytica is a rare, aerobic gram-negative bacillus from the Enterobacteriaceae family with some similarities to Klebsiella.
R. ornithinolytica has been associated with different clinical scenarios but this is the first reported case of wound infection and fat necrosis after breast reduction surgery ascribable to this pathogen.
Resistance to aminopenicillin is common and multidrug resistance is possible.
Mortality attributable to Raoultella has been reported despite appropriate antibiotic management.
Footnotes
Contributors: FA contributed to the initiation, design and writing of this manuscript. All authors contributed to the editing and proofreading of this manuscript.
Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests: None declared.
Patient consent: Obtained.
Provenance and peer review: Not commissioned; externally peer reviewed.
References
- 1. Heggendorn FL, Gonçalves LS, Dias EP, et al. Detection of sulphate-reducing bacteria in human saliva. Acta Odontol Scand 2013;71:1458–63. 10.3109/00016357.2013.770163 [DOI] [PubMed] [Google Scholar]
- 2. Kanki M, Yoda T, Tsukamoto T, et al. Klebsiella pneumoniae produces no histamine: Raoultella planticola and Raoultella ornithinolytica strains are histamine producers. Appl Environ Microbiol 2002;68:3462–6. 10.1128/AEM.68.7.3462-3466.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Drancourt M, Bollet C, Carta A, et al. Phylogenetic analyses of Klebsiella species delineate Klebsiella and Raoultella gen. nov., with description of Raoultella ornithinolytica comb. nov., Raoultella terrigena comb. nov. and Raoultella planticola comb. nov. Int J Syst Evol Microbiol 2001;51(Pt 3):925–32. 10.1099/00207713-51-3-925 [DOI] [PubMed] [Google Scholar]
- 4. Pan Z, Liu R, Zhang P, et al. Combination of tigecycline and levofloxacin for successful treatment of nosocomial pneumonia caused by New Delhi metallo-β-lactamase-1-producing Raoultella planticola . Microb Drug Resist 2017;23:127–31. 10.1089/mdr.2015.0346 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Seng P, Boushab BM, Romain F, et al. Emerging role of Raoultella ornithinolytica in human infections: a series of cases and review of the literature. Int J Infect Dis 2016;45:65–71. 10.1016/j.ijid.2016.02.014 [DOI] [PubMed] [Google Scholar]
- 6. Cho YJ, Jung EJ, Seong JS, et al. A case of pneumonia caused by Raoultella planticola . Tuberc Respir Dis 2016;79:42–5. 10.4046/trd.2016.79.1.42 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Solak Y, Gul EE, Atalay H, et al. A rare human infection of Raoultella ornithinolytica in a diabetic foot lesion. Ann Saudi Med 2011;31:93–4. 10.5144/0256-4947.2011.93a [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Levorova J, Machon V, Guha A, et al. Septic arthritis of the temporomandibular joint caused by rare bacteria Raoultella ornithinolytica . Int J Oral Maxillofac Surg 2017;46:111–5. 10.1016/j.ijom.2016.09.008 [DOI] [PubMed] [Google Scholar]
- 9. Seng P, Theron F, Honnorat E, et al. Raoultella ornithinolytica: an unusual pathogen for prosthetic joint infection. IDCases 2016;5:46–8. 10.1016/j.idcr.2016.07.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Venus K, Vaithilingam S, Bogoch II. Septic arthritis of the knee due to Raoultella ornithinolytica . Infection 2016;44:691–2. 10.1007/s15010-016-0930-y [DOI] [PubMed] [Google Scholar]
- 11. Yamakawa K, Yamagishi Y, Miyata K, et al. Bacteremia caused by Raoultella ornithinolytica in two children. Pediatr Infect Dis J 2016;35:452–3. 10.1097/INF.0000000000001050 [DOI] [PubMed] [Google Scholar]
- 12. Hadano Y, Tsukahara M, Ito K, et al. Raoultella ornithinolytica bacteremia in cancer patients: report of three cases. Intern Med 2012;51:3193–5. 10.2169/internalmedicine.51.8349 [DOI] [PubMed] [Google Scholar]
- 13. Sibanda M. Primary peritonitis caused by Raoultella ornithinolytica in a 53‐year‐old man. JMM Case Rep 2014;1 10.1099/jmmcr.0.002634 [DOI] [Google Scholar]
- 14. Kabbara WK, Zgheib YR. Diabetic foot infection caused by Raoultella ornithinolytica . Am J Health Syst Pharm 2015;72:2147–9. 10.2146/ajhp150221 [DOI] [PubMed] [Google Scholar]
- 15. Khajuria A, Praharaj AK, Grover N, et al. First report of blaNDM-1 in Raoultella ornithinolytica . Antimicrob Agents Chemother 2013;57:1092–3. 10.1128/AAC.02147-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Sun F, Yin Z, Feng J, et al. Production of plasmid-encoding NDM-1 in clinical Raoultella ornithinolytica and Leclercia adecarboxylata from China. Front Microbiol 2015;6:458 10.3389/fmicb.2015.00458 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Walckenaer E, Poirel L, Leflon-Guibout V, et al. Genetic and biochemical characterization of the chromosomal class a beta-lactamases of raoultella (formerly Klebsiella) planticola and Raoultella ornithinolytica. Antimicrob Agents Chemother 2004;48:305–12. 10.1128/AAC.48.1.305-312.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Castanheira M, Deshpande LM, DiPersio JR, et al. First descriptions of blaKPC in Raoultella spp. (R. planticola and R. ornithinolytica): report from the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol 2009;47:4129–30. 10.1128/JCM.01502-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Kaya S, Bayramoğlu G, Sönmez M, et al. Raoultella ornithinolytica causing fatal sepsis. Braz J Infect Dis 2015;19:230–1. 10.1016/j.bjid.2014.12.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Park JS, Hong KH, Lee HJ, et al. Evaluation of three phenotypic identification systems for clinical isolates of Raoultella ornithinolytica . J Med Microbiol 2011;60(Pt 4):492–9. 10.1099/jmm.0.020768-0 [DOI] [PubMed] [Google Scholar]
- 21. Walckenaer E, Leflon-Guibout V, Nicolas-Chanoine MH. How to identify Raoultella spp. including R. ornithinolytica isolates negative for ornithine decarboxylase? The reliability of the chromosomal bla gene. J Microbiol Methods 2008;75:405–10. 10.1016/j.mimet.2008.07.011 [DOI] [PubMed] [Google Scholar]
- 22. Sękowska A. Raoultella spp.-clinical significance, infections and susceptibility to antibiotics. Folia Microbiol 2017;62:221–7. 10.1007/s12223-016-0490-7 [DOI] [PubMed] [Google Scholar]
- 23. Bhatt P, Tandel K, Das NK, et al. New Delhi metallo-β-lactamase producing extensively drug-resistant Raoultella ornithinolytica isolated from drain fluid following Whipple’s pancreaticoduodenectomy. Med J Armed Forces India 2015;71(Suppl 2):S609–11. 10.1016/j.mjafi.2015.01.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Muzslay M, Moore G, Alhussaini N, et al. ESBL-producing Gram-negative organisms in the healthcare environment as a source of genetic material for resistance in human infections. J Hosp Infect 2017;95:59–64. 10.1016/j.jhin.2016.09.009 [DOI] [PubMed] [Google Scholar]
- 25. Nakasone ES, Kaneshiro R, Min K, et al. Emergence of Raoultella ornithinolytica on O’ahu: a case of community-acquired R. ornithinolytica urinary tract infection. Hawaii J Med Public Health 2015;74:174–5. [PMC free article] [PubMed] [Google Scholar]
- 26. Demiray T, Koroglu M, Ozbek A, et al. A rare cause of infection, Raoultella planticola: emerging threat and new reservoir for carbapenem resistance. Infection 2016;44:713–7. 10.1007/s15010-016-0900-4 [DOI] [PubMed] [Google Scholar]
- 27. Sękowska A, Dylewska K, Gospodarek E, et al. Catheter-related blood stream infection caused by Raoultella ornithinolytica . Folia Microbiol 2015;60:493–5. 10.1007/s12223-015-0390-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Salmaggi C, Ancona F, Olivetti J, et al. Raoultella planticola-associated cholangitis and sepsis: a case report and literature review. QJM 2014;107:911–3. 10.1093/qjmed/hcu087 [DOI] [PubMed] [Google Scholar]
- 29. Ogunleye AA, Leroux O, Morrison N, et al. Complications after reduction mammaplasty: a comparison of wise pattern/inferior pedicle and vertical scar/superomedial pedicle. Ann Plast Surg 2017;79:13–16. 10.1097/SAP.0000000000001059 [DOI] [PubMed] [Google Scholar]
- 30. Sueifan M, Moog V, Rau E, et al. [Sepsis caused by Raoultella ornithinolytica in an immunocompetent patient]. Anaesthesist 2016;65:129–33. 10.1007/s00101-015-0130-7 [DOI] [PubMed] [Google Scholar]
- 31. Boattini M, Almeida A, Cardoso C, et al. Infections on the rise: Raoultella spp., clinical and microbiological findings from a retrospective study, 2010-2014. Infect Dis 2016;48:87–91. 10.3109/23744235.2015.1082619 [DOI] [PubMed] [Google Scholar]
- 32. Chun S, Yun JW, Huh HJ, et al. Clinical characteristics of Raoultella ornithinolytica bacteremia. Infection 2015;43:59–64. 10.1007/s15010-014-0696-z [DOI] [PubMed] [Google Scholar]
- 33. Manahan MA, Buretta KJ, Chang D, et al. An outcomes analysis of 2142 breast reduction procedures. Ann Plast Surg 2015;74:289–92. 10.1097/SAP.0b013e31829d2261 [DOI] [PubMed] [Google Scholar]
- 34. O' Connell K, Kelly J, Niriain U. A rare case of soft-tissue infection caused by Raoultella planticola . Case Rep Med 2010;2010:1–2. 10.1155/2010/134086 [DOI] [PMC free article] [PubMed] [Google Scholar]
